Trial Profile
Efficacy of a Calcimimetic (Cinacalcet) in the Long Term Control of Patients With Primary Hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary) ; Alendronic acid
- Indications Primary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms CA-PHP
- 23 Apr 2015 New trial record